Sign in

CIK 0001396814

  • Large accelerated filer

Pacira BioSciences, Inc.

Sign in to watch
Ticker
PCRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
510619477
Phone
+1 650-242-8052
Business address
2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
Former names
Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$217,920
in 1 filing, $218K under 10b5-1 plans

Net −$217,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. RIKER LAUREN −$218K Senior Vice President, Finance sold 9% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-11-17 Lee Frank D. Chief Executive Officer Returned to the company −660,830.84 $36.50 $24.1M 0
2026-11-17 Lee Frank D. Chief Executive Officer Returned to the company · Stock Option (Right to Buy) −692,512 0
2026-02-11 Lee Frank D. Chief Executive Officer Grant or award +261,818 660,830.84
2026-01-30 Lee Frank D. Chief Executive Officer Shares withheld for taxes −41,488 $20.54 $852K 399,012.84
2026-01-02 Lee Frank D. Chief Executive Officer Shares withheld for taxes −9,272 $24.46 $227K 440,500.84
2025-02-01 Lee Frank D. Chief Executive Officer Grant or award +350,000 448,409
2025-01-02 Lee Frank D. Chief Executive Officer Shares withheld for taxes −9,375 $18.33 $172K 98,409
2024-08-12 Lee Frank D. Chief Executive Officer Purchase +8,264 $12.10 $100K 107,784
2024-01-03 Lee Frank D. Chief Executive Officer Grant or award · Stock Option (Right to Buy) +692,512 692,512
2024-01-02 Lee Frank D. Chief Executive Officer Grant or award +99,520 99,520

Page 1 of 1 · 10 trades